Early Risk Stratification of Patient Hospitalized for SARS-CoV2 Infection: Critical COVID-19 France CCF
Sponsored by French Cardiology Society
About this trial
Last updated 5 years ago
Study ID
2020-02
Status
Completed
Type
Observational
Placebo
No
Accepting
18+ Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended 5 years ago
What is this trial about?
The COVID-19 pandemic of SARS CoV2 (Severe Acute Respiratory Syndrome, COVID-19) infection,
which is currently evolving in France, raises many questions about the clinical and
biological profile of infected hospitalized patients. If certain biological factors like
troponin, BNP (Brain Natriuretic Peptid), or clinical factors like cardiovascular history or
oncological history are associated with a worse prognosis, available data comes from studies
in Asia for the majority, or including a limited number of patients. Patient stratification
remains a major issue for patient sorting and early referral of patients.
What are the participation requirements?
Inclusion Criteria
- Patients hospitalized in cardiology unit or medicine conventional sector with diagnosis of COVID-19 (positive PCR (Polymerase Chain Reaction) or diagnosis presumed by the clinical and radiographic picture)
Exclusion Criteria
- Minors
- Pregnant women